Congratulations to Daniel Herranz Benito, Ph.D., on earning more than $2 million in grants to study
T-cell acute lymphoblastic leukemia (T-ALL).
Read more here.
Herranz, who was funded by the Leukemia Research Foundation in 2018, is a member of the Cancer Pharmacology Program at Rutgers Cancer Institute of New Jersey. He is an assistant professor of Pharmacology at the Robert Wood Johnson Medical School at Rutgers.
For additional information call:
Carl Alston, Director of Communications